Keyphrases
HER1
100%
Targeted Therapy
100%
Triple-negative Breast Cancer
100%
HER3
77%
Triple-negative Breast Cancer Cells
66%
Nanoparticles
55%
THZ1
44%
Specific Intent
44%
Drug Nanoparticles
44%
Anticancer Agents
22%
Breast Cancer Subtypes
22%
Overexpressing
22%
Form Cell
11%
Metastasis Rate
11%
Cross-linked
11%
HER2 Expression
11%
Cancer Cell Growth
11%
Invasion Inhibition
11%
Estrogen Receptor Status
11%
Cell Clusters
11%
Cancer Cell Clusters
11%
Migration Inhibition
11%
Affibody
11%
Breast Cancer Xenograft
11%
Healthy Mice
11%
Cancer Xenograft Model
11%
Functional DNA
11%
Mammary Tumor
11%
Small Molecules
11%
Metastatic Site
11%
Tumor Growth
11%
Poor Prognosis
11%
Small Molecule Drugs
11%
Multi-copy
11%
Cargo
11%
Effective Therapy
11%
Affibody Molecule
11%
Aggressive Subtypes
11%
Innovative Approach
11%
DNA Nanostructures
11%
New Therapies
11%
Primary Tumor
11%
Tumor Metastasis
11%
Cancer Metastasis
11%
Metastasis
11%
Chemotherapy
11%
Breast Cancer Treatment
11%
Brain Metastases
11%
Lung Metastasis
11%
Progesterone
11%
Pharmacokinetics
11%
Medicine and Dentistry
Cross-Link
100%
Triple Negative Breast Cancer
100%
Targeted Therapy
100%
Nanoparticle
64%
Cancer Cell
35%
Metastatic Carcinoma
21%
Breast Cancer
14%
Brain Metastasis
7%
Affibody Molecule
7%
Migration Inhibition
7%
Estrogen Receptor
7%
Cancer Therapy
7%
Cancer Growth
7%
Nanomaterial
7%
Tumor Growth
7%
Anticancer Drug
7%
Receptor
7%
Progesterone
7%
In Vitro
7%
Pharmacokinetics
7%
Breast Tumor
7%
Tumor Xenograft
7%
Lung Metastasis
7%
Anticarcinogen
7%
Primary Tumor
7%
Pharmacology, Toxicology and Pharmaceutical Science
Triple Negative Breast Cancer
100%
Nanoparticle
64%
Breast Cancer
14%
Anticarcinogen
7%
Pharmacokinetics
7%
Anticancer Drug
7%
Estrogen Receptor
7%
Brain Metastasis
7%
Metastasis
7%
Nanomaterial
7%
Progesterone
7%
Chemotherapy
7%
Cancer Growth
7%
Receptor
7%
Primary Tumor
7%
Lung Metastasis
7%
Breast Tumor
7%